Cytokine release syndrome (CRS) following treatment with tebentafusp, a novel bispecific TCR-anti-CD3 directed against gp100, in patients with advanced melanoma Meeting Abstract
| Authors: | Shoushtari, A.; Middleton, M.; Stevens, N.; Evans, T.; Infante, J.; Sznol, M.; Anthoney, A.; Gupta, A.; Woodcock, V.; Wiseman, T.; McAlpine, C.; Cohen, C.; Hamid, O. |
| Abstract Title: | Cytokine release syndrome (CRS) following treatment with tebentafusp, a novel bispecific TCR-anti-CD3 directed against gp100, in patients with advanced melanoma |
| Meeting Title: | 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 7 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Nov 6-10 |
| Meeting Location: | National Harbor, MD |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2019-11-01 |
| Start Page: | 283 |
| Language: | English |
| ACCESSION: | WOS:000496473200323 |
| PROVIDER: | wos |
| PMCID: | PMC6833180 |
| PUBMED: | 31694708 |
| DOI: | 10.1186/s40425-019-0764-0 |
| Notes: | Meeting Abstract: P828 -- Source: Wos |
